Work

Long Term Survival of GOG 252 ‘Randomized Trial of Intravenous Versus Intraperitoneal Chemotherapy plus Bevacizumab in Advanced Ovarian Carcinoma: An NRG Oncology/GOG Study’ (021)

Year: 2022

Type: article

Source: Gynecologic Oncology

DOI: 10.1016/s0090-8258(22)01239-2

Authors: Joan Walker, Brady Mark, Kathleen Moore, Krishnansu Tewari, Premal Thaker, Paul DiSilvestro, Linda Van Le, Saketh Guntupalli, Heidi Gray, Peter Rose, David Alberts, Keiichi Fujiwara, Robert Mannel, Carol Aghajanian, Larry Copeland, Gini Fleming

Institutions: University of Oklahoma, NRG Oncology, OU Health Stephenson Cancer Center, University of Oklahoma Health Sciences Center, University of California, Irvine, Washington University in St. Louis, University of North Carolina at Chapel Hill, University of Colorado Denver, University of Washington, Cleveland Clinic, Saitama International Medical Center, Saitama Medical University, Memorial Sloan Kettering Cancer Center, The Ohio State University, University of Chicago

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Reproductive Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4297770849

FWCI: 0.515

Cites:

Cited by: 3

Related to: 10